Citigroup’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Sell |
56,779
-93,271
| -62% | -$2.68M | ﹤0.01% | 2190 |
|
|
2025
Q1 | $5.03M | Buy |
150,050
+29,291
| +24% | +$982K | ﹤0.01% | 1390 |
|
|
2024
Q4 | $6.17M | Buy |
120,759
+55,934
| +86% | +$2.86M | ﹤0.01% | 1255 |
|
|
2024
Q3 | $3.31M | Buy |
64,825
+33,755
| +109% | +$1.72M | ﹤0.01% | 1645 |
|
|
2024
Q2 | $1.39M | Sell |
31,070
-216,980
| -87% | -$9.72M | ﹤0.01% | 2019 |
|
|
2024
Q1 | $11.6M | Buy |
248,050
+145,739
| +142% | +$6.82M | 0.01% | 831 |
|
|
2023
Q4 | $3.64M | Buy |
102,311
+18,539
| +22% | +$660K | ﹤0.01% | 1291 |
|
|
2023
Q3 | $2.49M | Buy |
83,772
+28,388
| +51% | +$844K | ﹤0.01% | 1357 |
|
|
2023
Q2 | $998K | Sell |
55,384
-48,433
| -47% | -$873K | ﹤0.01% | 2243 |
|
|
2023
Q1 | $1.67M | Buy |
103,817
+54,946
| +112% | +$882K | ﹤0.01% | 1649 |
|
|
2022
Q4 | $894K | Sell |
48,871
-21,615
| -31% | -$396K | ﹤0.01% | 2100 |
|
|
2022
Q3 | $1.38M | Buy |
70,486
+20,506
| +41% | +$403K | ﹤0.01% | 1871 |
|
|
2022
Q2 | $932K | Buy |
49,980
+34,510
| +223% | +$644K | ﹤0.01% | 2135 |
|
|
2022
Q1 | $340K | Sell |
15,470
-36,753
| -70% | -$808K | ﹤0.01% | 3091 |
|
|
2021
Q4 | $1.48M | Buy |
52,223
+28,460
| +120% | +$809K | ﹤0.01% | 2203 |
|
|
2021
Q3 | $500K | Buy |
23,763
+19,122
| +412% | +$402K | ﹤0.01% | 2889 |
|
|
2021
Q2 | $87K | Buy |
4,641
+1,835
| +65% | +$34.4K | ﹤0.01% | 3902 |
|
|
2021
Q1 | $43K | Sell |
2,806
-7,455
| -73% | -$114K | ﹤0.01% | 4116 |
|
|
2020
Q4 | $145K | Buy |
10,261
+5,254
| +105% | +$74.2K | ﹤0.01% | 3432 |
|
|
2020
Q3 | $78K | Sell |
5,007
-1,563
| -24% | -$24.3K | ﹤0.01% | 3258 |
|
|
2020
Q2 | $115K | Buy |
6,570
+3,353
| +104% | +$58.7K | ﹤0.01% | 3378 |
|
|
2020
Q1 | $47K | Buy |
3,217
+966
| +43% | +$14.1K | ﹤0.01% | 3819 |
|
|
2019
Q4 | $56K | Buy |
2,251
+1,067
| +90% | +$26.5K | ﹤0.01% | 3883 |
|
|
2019
Q3 | $18K | Sell |
1,184
-2,459
| -67% | -$37.4K | ﹤0.01% | 4321 |
|
|
2019
Q2 | $92K | Buy |
3,643
+933
| +34% | +$23.6K | ﹤0.01% | 3690 |
|
|
2019
Q1 | $61K | Buy |
2,710
+1,209
| +81% | +$27.2K | ﹤0.01% | 3893 |
|
|
2018
Q4 | $45K | Sell |
1,501
-445
| -23% | -$13.3K | ﹤0.01% | 3977 |
|
|
2018
Q3 | $56K | Buy |
+1,946
| New | +$56K | ﹤0.01% | 3992 |
|